SEARCH RESULTS FOR:
Wayne Barnett
PRINCIPAL CONSULTANT (STRUCTURAL GEOLOGY), SRK CONSULTING
British Columbia & Vancouver as a Global Mining Hub 2019
SRK Vancouver supports British Columbia and broader Canada with its range of services from exploration to reclamation.
Eric Bruggeman
CEO, SA CAPITAL EQUIPMENT EXPORT COUNCIL (SACEEC)
MACIG 2020 DRC Pre-Release Edition
The SACEEC assists its members to export their products in an effort to increase South Africa’s manufacturing capabilities.
Daara B. Patel
SECRETARY GENERAL, IDMA
The IDMA helps to guide India’s pharmaceutical industry along its rapid path of growth towards becoming the largest global supplier of safe and efficacious medicines.
Dr. Rao Vadlamudi
IMMEDIATE PAST PRESIDENT, INDIAN PHARMACEUTICAL ASSOCIATION AND PRESIDENT, COMMONWEALTH PHARMACISTS ASSOCIATION
The IPA has led India’s pharmaceutical industry from its early conception in 1939 to its rise to become ‘The Pharmacy of the World’ today, and in this interview sets out its views for the industry with GBR.
Nicolas Konialidis & Craig Mynhardt
CEO & GM FOR AFRICA, IMPALA TERMINALS
MACIG 2020 DRC Pre-Release Edition
Impala Terminals is expanding its services in sub Saharan Africa in tandem with the development of the mining industry and with the continents infrastructure developments.
Geert Klok
GENERAL MANAGER, GK ANCUABE GRAPHITE MINE, S.A.
MACIG 2020 DRC Pre-Release Edition
GK Ancuabe graphite mine has expanded its capacity, offering an alternative to graphite from China and demonstrating that successful mining can be achieved in Mozambique.
Gareth Clifton
GENERAL MANAGER MOZAMBIQUE, KENMARE RESOURCES
MACIG 2020 DRC Pre-Release Edition
Kenmare discusses its operations in Mozambique and the challenges currently facing the country.
Errol Smart
MD AND CEO, ORION MINERALS
MACIG 2020 DRC Pre-Release Edition
Orion Minerals will be South Africa’s next copper and zinc producer with the Prieska project being a copper-predominant project. Full development is scheduled to begin in early 2020.
U.S. Pharmaceuticals: The East Coast
United States Biopharmaceuticals 2019
From New England to the Mid-Atlantic, a rising tide lifts all boats across the biopharma value chain.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
